The long-term risks of end stage renal disease and mortality among first nations and non-first nations people with youth-onset diabetes

Canadian Journal of Diabetes

Volumn 38, Issue 4, 2014, Pages 237-243

  Dyck, Roland F ^a,b   Jiang, Ying ^c   Osgood, Nathaniel D ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Canada; Disparities; End stage renal disease; Epidemiology; First Nations; Indigenous; Mortality; Youth onset diabetes

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; END STAGE RENAL DISEASE; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HUMAN; INCIDENCE; LONG TERM RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; YOUNG ADULT; YOUTH ONSET DIABETES; COHORT STUDIES; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY FAILURE, CHRONIC; METHODS; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; SASKATCHEWAN;

ADOLESCENT; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY FAILURE, CHRONIC; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SASKATCHEWAN;

EID: 84905260679     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.03.005     Document Type: Article

References (36)

1. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Naqshbandi M., Harris S.B., Esler J.G., Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. Diabetes Res Clin Pract 2008, 82:1-17.
3. Dean H.J., Mundy R.L., Moffatt M. Non-insulin dependent diabetes mellitus in Indian children in Manitoba. Can Med Assoc J 1992, 147:52-57.
4. Dean H.J., Sellers E.A.C., Young T.K. Type 2 diabetes in youth in Manitoba, Canada, 1986-2002. Can J Diabetes 2003, 27:449-454.
5. Young T.K., Martens P.J., Taback S.P., et al. Type 2 diabetes mellitus in children: Prenatal and early infancy risk factors among native Canadians. Arch Pediatr Adolesc Med 2002, 156:651-655.
6. Sellers EAC, Hadjiyannakis S, Amed S, etal. Minimum prevalence of persistent albuminuria in youth <18 years of age with type 2 diabetes mellitus: A Canadian Paediatric Surveillance Program Study. Chicago, IL: American Diabetes Association Meeting, June 2013.
7. Dyck R.F., Osgood N.D., Gao A., Stang M.R. The epidemiology of diabetes mellitus among First Nations and non-First Nations children in Saskatchewan. Can J Diabetes 2012, 36:19-24. 10.1016/j.jcjd2011.11.001.
8. Dyck R.F., Osgood N.D., Lin T.H., et al. End-stage renal disease in people with diabetes: A comparison of First Nations people and other Saskatchewan residents from 1981-2005. Can J Diabetes 2010, 34:324-333.
9. Jiang Y., Osgood N., Lim H.J., Dyck R.F. Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes: A competing risks analysis. Can Med Assoc J 2014, 186:103-109.
10. Dyck R.F., Osgood N., Lin T.H., et al. Epidemiology of diabetes mellitus among First Nations and non-First Nations adults. Can Med Assoc J 2010, 182:249-256.
11. Clatworthy S.J. Re-assessing the population impacts of Bill C-31: Strategic research and analysis directorate 2004, Indian and Northern Affairs Canada, Ottawa, Ontario.
12. Statistics Canada. 2001 census Aboriginal population profiles. 2002. Released June 17, 2003. Last modified 11/30, 2005. Statistics Canada Catalogue no. 93F0043XIE.
13. Saskatchewan Health covered population 2007: Saskatchewan Health, Regina. June 2007. Accessed October 2008. http://www.health.gov.sk.ca/covered-population2007/csv.htm.
14. Hux J.E., Ivis F., Flintoft V., et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002, 25:512-516.
15. Guttmann A., Nakhla M., Henderson M., et al. Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes 2010, 11:122-128.
16. Amed S., Dean H.J., Panagiotopoulos C., et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: A prospective national surveillance study. Diabetes Care 2010, 33:786-791.
17. Fine J.P., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. JAm Stat Assoc 1999, 94:496-509.
18. Forsblom C., Harjutsalo V., Thorn L.M., et al. on behalf of the FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. JAm Soc Nephrol 2011, 22:537-544.
19. Pintilie M. Competing risks: A practical perspective 2006, John Wiley and Sons, Chichester.
20. Gray R.J. Aclass of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statis 1988, 16:1141-1154.
21. Dart A., Sellers E.A., Martens P.J., et al. High burden of kidney disease in youth-onset diabetes. Diabetes Care 2012, 35:1265-1271.
22. Lee E.T., Lu M., Bennett P.H., Keen H. Vascular disease in younger-onset diabetes: Comparison of European, Asian and American Indian cohorts of the WHO multinational study of vascular disease in diabetes. Diabetologia 2001, 44(suppl 2):S78-S81. the WHO Multinational Study Group.
23. Barroso I. Genetics of type 2 diabetes. Diabetes Med 2005, 22:517-535.
24. Dabalea D., Pettitt D.J. Intrauterine diabetic environment confers risk for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. JPediatr Endocrinol Metab 2001, 14:1085-1091.
25. Osgood N.D., Dyck R.F., Grassmann W.K. The inter- and intra-generational impact of gestational diabetes on the epidemic of type 2 diabetes. Am J Pub Health 2011, 101:173-179.
26. Nelson R.G., Morgenstern H., Bennett P.H. Intrauterine diabetes exposure andthe risk of renal disease in diabetic Pima Indians. Diabetes 1998, 47:1489-1493.
27. Dyck R.F., Klomp H., Tan L.K., Stang M.R. An association of maternal age and birth weight with end-stage renal disease in Saskatchewan. Am J Nephrol 2003, 23:395-402.
28. Dyck R.F., Bingham W.T., Lim H., et al. Decreased urine albumin:creatinine ratios in infants of diabetic mothers: Does exposure to diabetic pregnancies alter fetal renal development?. JDev Orig Health Dis 2011, 2:265-271.
29. Deved V., Jette N., Quan H., et al. Quality of care for First Nations and non-First Nations people with diabetes. Can J Am Soc Nephrol 2013, for the Alberta Kidney Disease Network. 10.2215/CJN.10461012.
30. Klomp H, Dyck RF, Sidhu N, et al. Measuring quality of diabetes care by linking health care system administrative databases with laboratory data. BMC Res Notes. Accessed January 2014. http://www.biomedcentral.com/1756-0500/3/233.
31. Dyck R.F., Naqshbandi Hayward M., Harris S.B. Prevalence, predictors and co-morbidities of chronic kidney disease among First Nations adults with diabetes: Results from the CIRCLE study. BMC Nephrol 2012, 13:57. on behalf of the CIRCLE Study Group. 10.1186/1471-2369-13-57.
32. Sellers E.A.C., Blydt-Hanson T.D., Dean H.J., et al. Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care 2009, 32:786-790.
33. Orchard T.J., Secrest A.M., Miller R.G., Costacou T. In the absence of renal disease, 20-year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010, 53:2312-2319.
34. Mendelson M., Cloutier J., Spence L., et al. Obesity and type 2 diabetes in a birth cohort of First Nations children born to mothers with pediatric-onset type 2 diabetes. Pediatr Diabetes 2011, 12:219-228.
35. Pavkov M.E., Bennett P.H., Knowler W.C., et al. Effect of youth-onset type 2 diabetes mellitus on end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 2010, 296:421-426.
36. Parving H.H., Hommel E., Smidt U.M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988, 297:1086-1091.